Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qsymia for Obesity Prevention in Adolescents
NCT05834062Phase 2Withdrawn
- Sponsor
- University of Minnesota
- Start
- Oct 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phentermine + topiramate in obesity, sponsored by University of Minnesota. Planned start Oct 2023; status: withdrawn.
02
Drugs
phentermine + topiramate
03
Conditions
obesity
Beyond the preview
Go deeper on NCT05834062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05834062.